INTRACRANIAL ATHEROSCLEROTIC STENOSIS
Clinical trials for INTRACRANIAL ATHEROSCLEROTIC STENOSIS explained in plain language.
Never miss a new study
Get alerted when new INTRACRANIAL ATHEROSCLEROTIC STENOSIS trials appear
Sign up with your email to follow new studies for INTRACRANIAL ATHEROSCLEROTIC STENOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain training and new drug combo tested to fight memory loss in stroke risk patients
Disease control Not yet recruitingThis study tests whether a tablet-based brain training program and/or a powerful cholesterol-lowering drug (PCSK9 inhibitor) can improve thinking and memory in 420 adults aged 55-80 with narrowed brain arteries. Participants will be split into four groups, combining or not combin…
Matched conditions: INTRACRANIAL ATHEROSCLEROTIC STENOSIS
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New shot aims to slash stroke risk by crushing cholesterol
Disease control Not yet recruitingThis Phase 3 trial tests a new injectable drug, ongericimab, in about 4,800 people who recently had a stroke due to narrowed arteries. The goal is to see if lowering LDL cholesterol more than current standard care can prevent future strokes, heart attacks, or death from heart dis…
Matched conditions: INTRACRANIAL ATHEROSCLEROTIC STENOSIS
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC